Therefore, whether the levels of CB1, CB2, NHE1, NHE3, TRPV1, NGF, GDNF and TAC1 gene expressions in GERD patients were altered and correlated to the severity of GERD symptoms was examined in this study. This evidence concerns the gene SLC9A1 and gastroesophageal reflux disease.